Study links mutations in protein to rare blood vessel condition

07/23/2009 | U.S. News & World Report

Canadian researchers said they identified genetic variations in thrombomodulin, a protein that plays a role in blood coagulation and preventing cell damage, that appear to increase the risk of atypical hemolytic-uremic syndrome. The findings could pave the way for treatments for aHUS, a rare blood vessel disorder caused by damage to endothelial cells, the lead researcher said.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX